ClinicalTrials.gov
ClinicalTrials.gov Menu

Family Cancer Literacy to Promote Mammography Screening Among Navajo Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01605630
Recruitment Status : Completed
First Posted : May 25, 2012
Last Update Posted : December 19, 2017
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Christi Patten, Mayo Clinic

Brief Summary:
The no show rate for mammography screening is high among Navajo women. One barrier to preventive screening is a lack of cancer literacy including low knowledge and cultural attitudes (e.g., fatalism) about screening. The investigators will examine the potential feasibility and acceptability of a cancer literacy intervention for families of Navajo women who have no showed for three consecutive times to mammography screening who have never or rarely been screened in the past.

Condition or disease Intervention/treatment Phase
Breast Cancer Behavioral: Family-based family cancer literacy intervention Behavioral: Control Phase 1

Detailed Description:

This proposal describes a community-based participatory research study to develop and pilot test a new behavioral intervention to promote mammography screening among Navajo women. From a public health perspective, the intervention has the potential to reach many Navajo women, as 80% of women scheduled for mammography appointments do not follow through. These women (over 1,500 each year) are referred to the Nation Breast and Cervical Cancer Prevention Program (NNBCCPP). A key barrier toward implementing cancer prevention and control efforts in the Navajo community is a lack of cancer literacy or cultural and conceptual knowledge regarding cancer. Other barriers to screening are fear of cancer, stigma of cancer (even talking about cancer) often experienced by the patient, family and community, and lack of knowledge about the etiology of cancer and importance of early detection. Therefore, communication about cancer is impeded within Navajo families and the community.

This proposal builds on our successful partnership and collaboration with Diné College (the Navajo tribal college). The proposed study is designed to assess the feasibility and potential efficacy of a cancer-literacy focused, family-based intervention on completion of mammography screening for Navajo women. The intervention will include culturally and linguistically appropriate educational materials about cancer (e.g., the Navajo Cancer Glossary). The project will be implemented in two phases. During Phase 1, the investigators will develop the family cancer literacy intervention with feedback from our community advisory committee. In addition, the Cancer Literacy Measure will be adapted for Navajo women through focus groups and individual interviews. Phase 2 will consist of a formative evaluation of the intervention. The NNBCCPP patient and a female family member will be randomly assigned in pairs to the control condition (existing NNBCCPP health education services, N=40 pairs) or to receive these health education services plus the family cancer literacy intervention (N=40 pairs). The investigators will assess the intervention's feasibility and acceptability as indicated by the recruitment and retention rates and qualitative ratings of treatment acceptability. In addition, the investigators will examine the effect of the intervention compared with the control group on the proportion of women who complete mammography screening at 3-month follow-up documented by NNBCCPP records. The investigators will also examine changes in Cancer Literacy Measure scores from baseline to 3-month follow-up among both patients and family members. The investigators expect that as a result of this project, the investigators will have developed a replicable, feasible, and acceptable intervention, the efficacy of which can be tested in future large-scale randomized clinical trials. In addition, the adapted Cancer Literacy Measure could be used in future cancer prevention and control projects within the Navajo Nation. The overall objective is to reduce breast cancer morbidity and mortality among Navajo women.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Family Cancer Literacy to Promote Mammography Screening Among Navajo Women
Study Start Date : March 2012
Actual Primary Completion Date : July 2016
Actual Study Completion Date : December 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Mammography

Arm Intervention/treatment
Experimental: Family-based cancer literacy intervention Behavioral: Family-based family cancer literacy intervention
family based counseling and materials provided in navajo/english including digital stories

Active Comparator: Control
Standard of care
Behavioral: Control
standard of care




Primary Outcome Measures :
  1. Acceptability of the intervention [ Time Frame: Participants will be assesed at 3 month follow-up ]
    Participants will be asked if they found the intervention to be helpful or not and if they would recommend it to other women


Secondary Outcome Measures :
  1. Changes in Cancer Literacy Measure [ Time Frame: participants will be assessed at baseline and at 3 month follow-up ]
    Participants will be asked about breast cancer screening knowledge and attitudes including cultural barriers to screening

  2. completion of mammography screening [ Time Frame: participants will be assessed from the time of enrollment to 3 month follow-up ]
    Based on program records we will determine if participants completed mammography screening or not



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

In Phase 1, we will recruit 17 Navajo women for individual interviews (n=5) and focus groups (n=12) to adapt our measures. Eligibility criteria are:

  1. aged 40 years or older and
  2. provides written informed consent. We chose to develop our measures based on feedback from the general community of women who are screening eligible instead of matching the inclusion/exclusion criteria to that used in the formative evaluation of the intervention (Phase 2). This will enhance our ability to use the Cancer Literacy Measure and other assessments in subsequent breast cancer prevention and control studies.

In Phase 2, we will recruit a total of 40 patient-family member pairs. To be eligible for the study, the NNBCCPP patient must:

  1. be aged 40 years or older,
  2. provide written informed consent,
  3. be referred to the NNBCCPP as a "no-show" for mammography screening after three scheduling attempts,
  4. have no prior history of mammography screening,
  5. have no prior history of breast cancer, and
  6. can identify a female family member or other individual who resides in or near the home who could participate in the project.

In addition, the family member must:

  1. be female,
  2. aged 18 years or older,
  3. be fluent and literate in Navajo,
  4. be interested and able to participate, and
  5. provide written informed consent.

Exclusion Criteria:

Phase 2: History of breast cancer or mammography screening


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01605630


Locations
United States, New Mexico
Dine College
Shiprock, New Mexico, United States, 87420
Sponsors and Collaborators
Mayo Clinic
National Cancer Institute (NCI)
Investigators
Principal Investigator: Christi A Patte, PhD Mayo Clinic

Responsible Party: Christi Patten, Professor of Psychology, Mayo Clinic
ClinicalTrials.gov Identifier: NCT01605630     History of Changes
Other Study ID Numbers: 11-004328
R21CA152433 ( U.S. NIH Grant/Contract )
First Posted: May 25, 2012    Key Record Dates
Last Update Posted: December 19, 2017
Last Verified: December 2017